Parallel Bio

Watertown, United States

Parallel Bio develops tools that help in the discovery and development of immunotherapies.

$21.0M raised

Jun 2025

Series A

Top Investors

Y CombinatorAIX VenturesAmploBreakout VenturesRefactor

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Parallel Bio raised?

Parallel Bio has raised $21.0M in total funding. The most recent round was Series A. The last funding was announced in June 2025.

Who are Parallel Bio's investors?

Parallel Bio's investors include Y Combinator, AIX Ventures, Amplo, Breakout Ventures, Refactor.

Where is Parallel Bio headquartered?

Parallel Bio is headquartered in Watertown, United States.

What does Parallel Bio do?

Parallel Bio develops tools that help in the discovery and development of immunotherapies.

What stage is Parallel Bio at?

Parallel Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 11, 2025.

MLA

"Parallel Bio — Funding & Investors." VCBacked, June 11, 2025, https://www.vcbacked.co/company/parallel-bio. Accessed June 17, 2026.

APA

VCBacked. (2025). Parallel Bio — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/parallel-bio

Wikipedia (cite web)

{{cite web |title=Parallel Bio — Funding & Investors |url=https://www.vcbacked.co/company/parallel-bio |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 11, 2025.